Spiderwort is developing a novel biomaterial that will offer new avenues in regenerative medicine. We are using plant derived cellulose to create a variety of scaffold architectures. Currently, we are in the pre-clinical stage of this product and our promising results demonstrate that this new biomaterial is highly biocompatible and induceangiogenesis (blood vessel generation inside the scaffold).

Biotechnology

Health Care

Spiderwort Inc.

Spiderwort Inc.'s headquarters in Ottawa, Canada

Charles M. Cuerrier

Julie Guindon - flexHR

Stephen Hanson

Scott Jarvis, Virtual CFO

Andrew Pelling

The Research and Development team at Spiderwort Inc. is dedicated to pioneering the application of plant-derived cellulose in regenerative medicine. Focusing on innovative scaffold architectures, the team conducts rigorous pre-clinical research to assess the biocompatibility and angiogenic properties of their novel biomaterials. Their collaborative efforts aim to translate scientific discoveries into viable therapeutic solutions for tissue regeneration.

Research and Development

The Leadership Team at Spiderwort Inc. is responsible for setting the strategic direction of the company, overseeing the development of innovative biomaterials for regenerative medicine, and ensuring financial sustainability. Comprised of key roles—including the Co-founder and Chief Scientific Officer, CEO and Co-founder, and Chief Financial Officer—this team drives research initiatives, fosters partnerships, and navigates pre-clinical progress to bring plant-derived cellulose scaffolds to market.

Spiderwort Inc.

Org chart

Teams

Research and Development

Leadership Team

Offices

Spiderwort Inc.

Org chart

Teams

Research and Development

Leadership Team

Offices

Related companies